Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Updated CDC HIV Testing Guidelines to Shape Evolving Diagnostics Market

Published by: Decision Resources

Published: Mar. 26, 2007 - 39 Pages

The price of this report has been reduced due to its age. The original price was $2,025 for PDF.

Table of Contents


Executive Summary

Strategic Considerations

Stakeholder Implications

Introduction

Revised Guidelines and Target Populations

HIV Testing and Prevention Trends

Background on HIV Guidelines and Impact of New Guidelines

Factors Infl uencing the CDC Recommendations for Routine Screening

Screening for HIV in the Health Care Setting

Advantages of Rapid Screening Tests

Monitoring of HIV-Infected Adults and Adolescents

Baseline Measurement

Timing of Treatment Initiation

Timing of Therapy Switch

Response of Various Professional Groups

Regulation of HIV Diagnostics

Impact of Routine HIV Testing on Patient Groups

People Unaware of Their HIV Serostatus

People Diagnosed at an Advanced Stage of Disease

Pregnant Women

Current Diagnostics

Screening Tests

Confi rmatory Tests

Monitoring Tests

CD4 T-Cell Count

Viral Load Test

Resistance Tests

Emerging Diagnostics

Over-the-Counter HIV Home Test Kits

Viral Fitness (Replication Capacity) Tests

CCR5 and CXCR4 Tropism Tests

Select Key Players in HIV Diagnostics

OraSure Technologies

BioMérieux

Outlook

Impact of CDC Guidelines on Routine HIV Screening

Impact on Diagnostics Sectors

Impact on Drug Treatment

Constraints on Routine HIV Testing

Strategic Considerations

Development of Improved and New Products

Infl uencing Decision Makers

Synergy with Drugs

Appendix A. Bibliography

Appendix B. Explanation of Terms Used in This Report

Abstract

HIV/AIDS stands out as a highly lucrative and expanding market for diagnostics companies because of the close integration of diagnostics in initial diagnosis and subsequent day-to-day disease management. With the newly released CDC screening recommendations advocating increased testing for the infection, diagnostics will play an increasingly critical role in HIV disease management.

Get the Answers You Need to Shape Your Strategy
  • The revised CDC guidelines for HIV testing are set to dramatically benefi t the HIV diagnostics market in the United States. Which sectors of the diagnostics market will benefi t most? What will be the long-term impact of the CDC recommendations?
  • The new recommendations have changed HIV testing from an “opt-in” diagnostic to an “opt-out” test that is a routine part of medical practice. How will this new process affect the diagnosis rates for HIV? Will it dramatically increase treatment rates?
  • HIV diagnosis is currently a multistep process that involves time-consuming confi rmatory tests. In its new recommendations, the CDC advocates the use of rapid testing. How will the CDC recommendations impact the rapid testing arena? Which companies are the key players in this sector?
  • With the increase in drug resistance among HIV/AIDS patients, resistance testing is playing a growing role in HIV disease management. Will the new CDC recommendations increase use of monitoring tests as well? What unmet needs remain in the resistance testing sector? Which companies are active in this area?


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options
See related reports or call the number above for help from a research specialist.


advertise with us

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008